Results 161 to 170 of about 115,492 (300)

Censorship and the institution of knowledge in Bacon’s New Atlantis [PDF]

, 2018
openaire   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, Qing‐Wen Wang, James Cheng Chung Wei   +3 more
wiley   +1 more source

Why the European Journal of Public Health and EUPHA are opposing President Trump's attack on the language of diversity. [PDF]

Eur J Public Health
Allebeck P, Albreht T, Marchandise C, McKee M.   +3 more
europepmc   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Robust Uncertainty-Informed Glaucoma Classification Under Data Shift. [PDF]

Transl Vis Sci Technol
Rashidisabet H, Chan RVP, Leiderman YI, Vajaranant TS, Yi D.   +4 more
europepmc   +1 more source

Penal Regimes and Dissenters in the Soviet Orbit [PDF]

, 1979
Grzybowski, Kazimierz
core   +2 more sources

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) using three independent cohorts. Methods We first assessed the association of a panel of IPF‐associated biomarkers with prevalent ILD ...
Brent A. Luedders, Daniel Kass, Joshua F. Baker, Michael J. Duryee, Yangyuna Yang, Punyasha Roul, Halie Frideres, Katherine D. Wysham, Paul A. Monach, Andreas Reimold, Gail S. Kerr, Gary Kunkel, Grant W. Cannon, Scott M. Matson, Jill A. Poole, Geoffrey M. Thiele, Ted R. Mikuls, Bryant R. England, Dana P. Ascherman   +18 more
wiley   +1 more source

Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis–related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang, Shuo Liu, Michael Wax II, Seoyeon Lee, Sarah French, Paul J. Wolters, Francesco Boin   +6 more
wiley   +1 more source

Exploring Self-Censorship and Self-Disclosure Among Clinical Medical Students with Minoritized Identities. [PDF]

Perspect Med Educ
Sankar V, Atkinson TM, Sukhera J.
europepmc   +1 more source

Prosocial motives underlie scientific censorship by scientists: A perspective and research agenda. [PDF]

Proc Natl Acad Sci U S A, 2023
Clark CJ, Jussim L, Frey K, Stevens ST, Al-Gharbi M, Aquino K, Bailey JM, Barbaro N, Baumeister RF, Bleske-Rechek A, Buss D, Ceci S, Del Giudice M, Ditto PH, Forgas JP, Geary DC, Geher G, Haider S, Honeycutt N, Joshi H, Krylov AI, Loftus E, Loury G, Lu L, Macy M, Martin CC, McWhorter J, Miller G, Paresky P, Pinker S, Reilly W, Salmon C, Stewart-Williams S, Tetlock PE, Williams WM, Wilson AE, Winegard BM, Yancey G, von Hippel W.   +38 more
europepmc   +1 more source